Nathaniel Calloway - 01 Feb 2023 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/Aaron Perlitsh
Issuer symbol
LFCR
Transactions as of
01 Feb 2023
Net transactions value
$0
Form type
4
Filing time
02 Feb 2023, 16:30:26 UTC
Previous filing
11 Jan 2023
Next filing
05 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Unit Award +3,981 3,981 01 Feb 2023 Common Stock 3,981 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.